ALEXANDRA KUHN: Open Payments
NPI 1497344527 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 111 payments from 14 companies in 2025. Trend: 2023 $1,929 · 2024 $1,178 · 2025 $1,859
Food & beverage: $1,799Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $439 |
| Novartis Pharmaceuticals Corporation | 19 | $265 |
| Amgen Inc. | 14 | $224 |
| Janssen Biotech, Inc. | 10 | $177 |
| E.R. Squibb & Sons, L.L.C. | 12 | $161 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| GlaxoSmithKline, LLC. | 7 | $143 |
| Organon LLC | 5 | $105 |
| UCB, Inc. | 4 | $80 |
| GENZYME CORPORATION | 1 | $27 |
Products named: COSENTYX, SKYRIZI, RINVOQ, TREMFYA, ORENCIA, BENLYSTA, OTEZLA, HADLIMA.
Industry payments across TX — which companies pay providers there.
